Tag Archives: data

Array’s colorectal cancer data shows why Pfizer splashed out $11B for the biotech

One key incentive for Pfizer paying $ 11 billion for Array BioPharma was the positive early readouts from its triplet therapy for colorectal cancer. Now, the biotech has shown exactly how attractive that data are. A combination of Array’s BRAF inhibitor Braftovi, its MEK inhibitor Mektovi and the anti-EGFR drug Erbitux significantly extended lives of previously-treated patients… Read More »

XX Marks the Spot: Why Did Women Tech Experts Rule at DC Health Data Confab?

By MICHAEL L. MILLENSON Three government experts on a health tech conference panel discuss the urgency of releasing actionable data; all are women. A more senior official, another woman, gives a TED-style talk making the same case. And a four-person, private-sector panel debates privacy and ethics; three of the four are female. Health Datapalooza, a… Read More »

FDA uncovers data manipulation at Immunomedics plant making cancer drug

Immunomedics received an FDA complete response letter last month tied to manufacturing concerns about its breast cancer antibody-drug conjugate. When pressed by analysts, company executives dodged questions of whether it stemmed from a preapproval inspection of its plant last year. Now the FDA has released the Form 483 from the inspection showing big issues with data… Read More »

ONC to Congress: Room for improvement in data sharing

Dive Brief: Despite widespread EHR adoption, providers, patients and payers still face significant hurdles in accessing and sharing data, the Office of the National Coordinator for Health Information Technology says in its latest progress report to Congress. The 22-page report, released this week, covers the timeframe of November 2016 through October 2018. Ongoing barriers to seamless… Read More »